Gene: BANK1
Official Full Name: B cell scaffold protein with ankyrin repeats 1provided by HGNC
Gene Summary: The protein encoded by this gene is a B-cell-specific scaffold protein that functions in B-cell receptor-induced calcium mobilization from intracellular stores. This protein can also promote Lyn-mediated tyrosine phosphorylation of inositol 1,4,5-trisphosphate receptors. Polymorphisms in this gene are associated with susceptibility to systemic lupus erythematosus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19488 | BANK1 Knockout cell line (HeLa) | Human | BANK1 | 1:3~1:6 | Negative | Online Inquiry |
KO19489 | BANK1 Knockout cell line (HCT 116) | Human | BANK1 | 1:2~1:4 | Negative | Online Inquiry |
KO19490 | BANK1 Knockout cell line (A549) | Human | BANK1 | 1:3~1:4 | Negative | Online Inquiry |
BANK1 Gene Knockout Cell Lines are meticulously developed cellular models that feature the targeted inactivation of the BANK1 gene, an important regulator involved in immune responses and autoimmune disorders. Utilizing advanced CRISPR/Cas9 genome-editing technologies, these cell lines provide researchers with a precise tool to study the role of BANK1 in various biological processes such as B-cell signaling, immune regulation, and the pathophysiology of diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
The primary function of the BANK1 gene involves the modulation of signal transduction pathways that influence cell survival, proliferation, and differentiation within lymphocytes. By knocking out this gene, researchers can assess the downstream effects on immune cell function, elucidating the molecular mechanisms underpinning autoimmunity and other related disorders. This can lead to a deeper understanding of how dysregulation of the BANK1 gene contributes to disease states, thereby identifying potential therapeutic targets.
The scientific significance of BANK1 Gene Knockout Cell Lines spans both research and clinical settings. These cell lines facilitate high-throughput screening of pharmacological agents and genetic manipulation studies, providing insights into drug development for autoimmune diseases. Additionally, they serve as powerful models for dissecting complex interactions within the immune system, thereby advancing the field of immunology.
Compared to standard models, our BANK1 Gene Knockout Cell Lines offer enhanced accuracy in reflecting the effects of gene inactivation, owing to the precise genomic modification achieved through CRISPR technology. This specificity ensures that any observed phenotypic variations are attributable to the BANK1 deletion, thereby enhancing the reproducibility and reliability of experimental outcomes.
For researchers, clinicians, and biotech professionals, these knockout cell lines represent an invaluable resource for dissecting the complexities of immune regulation and autoimmune pathology. By leveraging the unique features of the BANK1 knockout model, users can advance their research with greater confidence in the validity of their findings.
At our company, we pride ourselves on our commitment to providing state-of-the-art biological tools grounded in rigorous scientific validation. Our expertise in developing innovative cell line models ensures that researchers have access to high-quality resources that can significantly enhance their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.